Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 1/20 | 0.58 |
| ▸ | ACHE | P22303 | 1/20 | 0.58 |
| ▸ | CNR2 | P34972 | 1/20 | 0.58 |
| ▸ | PDE5A | O76074 | 4/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | NPC1 | O15118 | 1/20 | 0.52 |
| ▸ | GMNN | O75496 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | TP53 | P04637 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.52 |
| ▸ | HPGD | P15428 | 1/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10627901 | 0.98 | CNR1 (0.56) | CNR1ACHECNR2PDE5ACYP1A2 | |
| SCHEMBL10627892 | 0.98 | CNR1 (0.56) | CNR1ACHECNR2PDE5ACYP1A2 | |
| SCHEMBL516208 | 0.83 | CNR2 (0.66) | CNR1ACHECNR2KDM4EALDH1A1 | |
| SCHEMBL30602811 | 0.81 | PTGDR2 (0.46) | CNR1ACHECNR2PDE5ACYP1A2 | |
| SCHEMBL9917435 | 0.81 | PDE5A (0.49) | CNR1ACHECNR2PDE5AKDM4E | |
| SCHEMBL17696321 | 0.80 | CNR1 (0.59) | CNR1ACHECNR2PDE5ACYP1A2 | |
| SCHEMBL29342349 | 0.80 | CNR1 (0.59) | CNR1ACHECNR2PDE5ACYP1A2 | |
| SCHEMBL928055 | 0.79 | SLC16A3 (0.58) | CNR1ACHECNR2PDE5ACYP1A2 | |
| SCHEMBL29562418 | 0.79 | SLC16A3 (0.58) | CNR1ACHECNR2PDE5ACYP1A2 | |
| SCHEMBL1226080 | 0.79 | CNR1 (0.58) | CNR1ACHECNR2PDE5ACYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8822396-B2 | Solution for removing residue after semiconductor dry process and method of removing the residue using the same | DAIKIN INDUSTRIES, LTD. (JP) | 2014-09-02 | — | — | US | claimed |
| CN-102839062-A | Application of residue-removing solution | DAIKIN IND LTD | 2012-12-26 | — | — | CN | claimed |
| US-20100203735-A1 | SOLUTION FOR REMOVING RESIDUE AFTER SEMICONDUCTOR DRY PROCESS AND METHOD OF REMOVING THE RESIDUE USING THE SAME | DAIKIN INDUSTRIES, LTD. (JP) | 2010-08-12 | — | — | US | claimed |
| CN-101785087-A | Residue removing liquid after semiconductor dry process and residue removing method using the same | DAIKIN IND LTD | 2010-07-21 | — | — | CN | claimed |
| US-20240216332-A1 | METHOD AND PHARMACEUTICAL COMPOSITION FOR TREATING MYOPIA | GRAND PHARMA (CHINA) CO., LTD. (CN) | 2024-07-04 | — | — | US | disclosed |
| CN-118236372-A | Medicament and method for treating myopia | 温州医科大学附属眼视光医院 | 2024-06-25 | — | — | CN | disclosed |
| EP-4324463-A1 | METHOD AND PHARMACEUTICAL COMPOSITION FOR TREATING MYOPIA | Grand Pharma (China) Co., Ltd. (CN) | 2024-02-21 | — | — | EP | disclosed |
| CN-110036341-B | Photosensitive resin composition, photosensitive resin laminate, method for producing resin pattern, and method for producing cured film pattern | 旭化成株式会社 | 2023-06-09 | — | — | CN | disclosed |
| CN-114609864-A | Photosensitive resin composition | 旭化成株式会社 | 2022-06-10 | — | — | CN | disclosed |
| CN-106918995-B | Photosensitive resin composition, photosensitive resin laminate, method for producing resin pattern and cured film pattern, and display device | 旭化成株式会社 | 2020-06-02 | — | — | CN | disclosed |
| WO-2019164016-A1 | TRANSFER FILM, RESIN PATTERN FORMING METHOD USING TRANSFER FILM, AND CURED FILM PATTERN FORMING METHOD | 旭化成株式会社 | 2019-08-29 | — | — | WO | disclosed |
| CN-110036341-A | Photosensitive resin composition, photosensitive resin laminate, method for producing resin pattern, and method for producing cured film pattern | 旭化成株式会社 | 2019-07-19 | — | — | CN | disclosed |
| US-20100015093-A1 | Methods and compositions of treating a flaviviridae family viral infection | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 2010-01-21 | — | — | US | disclosed |
| US-20100015093-A1 | Methods and compositions of treating a flaviviridae family viral infection | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 2010-01-21 | — | — | US | disclosed |
| US-20040048866-A1 | Indazole derivatives that are activators of soluble guanylate cyclase | ABBOTT LABORATORIES | 2004-03-11 | — | — | US | disclosed |
| WO-2003076408-A2 | INDAZOLE DERIVATIVES THAT ARE ACTIVATORS OF SOLUBLE GUANYLATE CYCLASE | ABBOTT LABORATORIES (US) | 2003-09-18 | — | — | WO | disclosed |
| WO-2000027394-A1 | ACTIVATORS OF SOLUBLE GUANYLATE CYCLASE | UNIVERSITY COLLEGE LONDON (GB) | 2000-05-18 | — | — | WO | disclosed |
| US-5965582-A | ANTIHISTAMINES | ASTA MEDICA AKTIENGESELLSCHAFT (DE) | 1999-10-12 | — | — | US | disclosed |
| US-5776932-A | ANTIALLERGENS, ANTIASTHMATICS, ANTIINFLAMMATORY AGENTS AND MODULATORS | ARZNEIMITTELWERK DRESDEN G.M.B.H. (DE) | 1998-07-07 | — | — | US | disclosed |
| US-4749794-A | REMOVING 1-CHLORO-3-METHYLAMINOPROPANE IMPURITY FROM CRUDE PRODUCT | AZIENDE CHIMICHE RIUNUTE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) | 1988-06-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040048866-A1 | Indazole derivatives that are activators of soluble guanylate cyclase | GUCY1B1, GUCY1A1, GUCY1A2 | CNR1 1179/4885ACHE 710/4885CNR2 1561/4885 |
| US-20100015093-A1 | Methods and compositions of treating a flaviviridae family viral infection | EIF2AK2, NSUN3, NSUN2 | CNR1 3683/4885ACHE 3660/4885CNR2 3370/4885 |
| US-20240216332-A1 | METHOD AND PHARMACEUTICAL COMPOSITION FOR TREATING MYOPIA | MYOC, PDE6H, RHOA | CNR1 856/4885ACHE 235/4885CNR2 536/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.